Skip to main content
All lobbying clients

FOUNDATION MEDICINE

Lobbying client · Massachusetts · filed 2025 to 2026

Molecular insight company, connects physicians & patients to the latest cancer treatment

$1,120,000 Reported spend
14 Filings counted
1 Outside firm hired
4 Bills named

Spend is reported income plus in-house expenses across 14 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as FOUNDATION MEDICINE, INC.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 4
  • H.R. 5377
    Cancer Patient Equity Act of 2021
    1 filing
  • H.R. 2369
    PHIT Act of 2025
    1 filing
  • H.R. 3561
    FORCE Act
    1 filing
  • H.R. 8646
    Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
    1 filing
 Reported by year 2 years
  • 2026 $480,000 6 filings
  • 2025 $640,000 8 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 10
  • SENATE 10
  • Food & Drug Administration (FDA) 9
  • Centers For Medicare and Medicaid Services (CMS) 5
  • Homeland Security, Dept of (DHS) 5
  • U.S. Customs & Border Protection 1
 Recent filings 14 total
Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 20, 2026
View → Q3 report
FOUNDATION MEDICINE, INC.
3rd Quarter 2026 (July 1 - Sep 30) · $80,000 expenses · posted Oct 15, 2026
View → Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 16, 2026
View → Q2 report
FOUNDATION MEDICINE, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $80,000 expenses · posted Jul 16, 2026
View → Q1 report
TARPLIN, DOWNS & YOUNG, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 20, 2026
View → Q1 report
FOUNDATION MEDICINE, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · $80,000 expenses · posted Apr 16, 2026
View → Q4 report
TARPLIN, DOWNS & YOUNG, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $80,000 income · posted Jan 20, 2026
View → Q4 report
FOUNDATION MEDICINE, INC.
4th Quarter 2025 (Oct 1 - Dec 31) · $80,000 expenses · posted Jan 15, 2026
View → Q3 report
FOUNDATION MEDICINE, INC.
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $80,000 expenses · posted Oct 17, 2025
View → Q3 report
TARPLIN, DOWNS & YOUNG, LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $80,000 income · posted Oct 16, 2025
View → Q2 report
FOUNDATION MEDICINE, INC.
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $80,000 expenses · posted Jul 18, 2025
View → Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $80,000 income · posted Jul 16, 2025
View → Q1 reportNo activity
FOUNDATION MEDICINE, INC.
1st Quarter 2025 (Jan 1 - Mar 31) · $80,000 expenses · posted Apr 18, 2025
View → Q1 report
TARPLIN, DOWNS & YOUNG, LLC
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 16, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem